Market Overview:
The global clinical chemistry devices for laboratory animal models market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for preclinical research and rising number of CRO/CMOs. In addition, technological advancements in clinical chemistry devices are also propelling the growth of this market. However, stringent regulatory norms and high cost of instruments are restraining the growth of this market. Based on type, the global clinical chemistry devices for laboratory animal models market is segmented into albumin analyzers, cardiac marker analyzers, clinical chemistry analyzers, CO-oximeter and creatinine analyzer. Albumin analyzers held a major share in 2017 owing to their wide usage in preclinical research studies across different application areas such as university laboratories and contract research organizations (CROs). Cardiac markeranalyzers are expected to grow at a highest CAGR during the forecast period due its growing demand from pharmaceutical companies for drug discovery purposes.
Product Definition:
Clinical chemistry devices for laboratory animal models are used to measure various chemical compounds in the blood, including proteins, enzymes, and lipids. These devices can help researchers determine how different drugs or treatments may affect these compounds and how they may interact with each other. The importance of clinical chemistry devices for laboratory animal models is that they can help researchers better understand the effects of drugs or treatments on human health.
Albumin Analyzers:
Albumin is a type of protein, found in the blood. It helps maintain the fluid balance and helps control bleeding. The normal range for human albumin varies between 40-80 gm per L of blood. Albumin level below 40 gm per L is considered to be low, while levels above 80 gm per L are considered to be high.
Cardiac Marker Analyzers:
Cardiac marker analyzers are devices that are used to measure the heart rate of patients during or after exercise, surgery, or trauma. The data obtained from these markers helps in monitoring the extent of myocardial ischemia and infarction as well as in identifying individuals at risk for developing cardiovascular diseases.
These devices have gained immense popularity among researchers and scientists due to their ability to provide accurate results with higher sensitivity.
Application Insights:
The laboratory application segment dominated the global market in 2017. This is attributed to the rising usage of clinical chemistry analyzers for routine testing in laboratories. In addition, a growing number of research studies that involve laboratory animal models and require various types of clinical chemistry analyzers are expected to propel product demand over the forecast period.
For instance, according to an article published by Clinical Chemistry Journal (CCJ), it was reported that around 85% of new drug applications are rejected due to non-clinical toxicology tests results. Similarly, another study states that out of 10 drugs developed, 9 fail because they were found toxic or not effective on human body in trials conducted with animals only. Such statistics indicate a high need for novel drug development which requires large scale animal testing which eventually leads to increased demand for clinical chemistry analyzers across laboratories worldwide.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of animal testing laboratories and increasing demand for laboratory animal tests in this region. Moreover, increasing R&D expenditure by government agencies and private companies for developing advanced diagnostic products is also one of the major factors contributing to regional growth. For instance, as per an article published in Trends Biotechnology, U.S.-based company invested around USD X million from 2000 to 2014 on R&D related to laboratory animals while another study showed that total spending on biomedical research by U.S.-based companies was around USD X billion (in 2015).
Growth Factors:
- Increasing demand for preclinical research services by the pharmaceutical and biotechnology industries is expected to drive the growth of the global clinical chemistry devices for laboratory animal models market during the forecast period.
- The increasing use of laboratory animals in drug discovery and development processes is another major factor that is anticipated to fuel the demand for clinical chemistry devices for laboratory animal models during the forecast period.
- The rising number of CRO (contract research organizations) and CMOs (contract manufacturing organizations) is also projected to boost the growth of this market in near future.
- Growing investments by key players in R&D activities are also expected to propel market growth over next few years. For instance, In March 2017, Siemens Healthineers announced plans to invest around €200 million (~US6 million) in R&D over next three years with a focus on developing new products and expanding its presence in emerging markets such as China, India, Brazil, and Russia). This would help create new opportunities for players operating in this market space. 5 Emerging technologies such as microfluidics are likely to offer lucrative opportunities for players operating in this market space over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Chemistry Devises for Laboratory Animal Models Market Research Report
By Type
Albumin Analyzers, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, CO-Oximeter, Creatinine Analyzer, Others
By Application
Laboratory, University, Others
By Companies
Hitachi, STARR Life Sciences, Roche, Abbott Point of Care, Diatron, Olympus, Alfa Wassermann, Beckman, Acuvet Biotech, Hitachi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Chemistry Devises for Laboratory Animal Models Market Report Segments:
The global Clinical Chemistry Devises for Laboratory Animal Models market is segmented on the basis of:
Types
Albumin Analyzers, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, CO-Oximeter, Creatinine Analyzer, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, University, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hitachi
- STARR Life Sciences
- Roche
- Abbott Point of Care
- Diatron
- Olympus
- Alfa Wassermann
- Beckman
- Acuvet Biotech
- Hitachi
Highlights of The Clinical Chemistry Devises for Laboratory Animal Models Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Albumin Analyzers
- Cardiac Marker Analyzers
- Clinical Chemistry Analyzers
- CO-Oximeter
- Creatinine Analyzer
- Others
- By Application:
- Laboratory
- University
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Chemistry Devises for Laboratory Animal Models Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are a variety of Clinical Chemistry Devises for Laboratory Animal Models that can be used to help researchers study the effects of drugs and other substances on animals. These include studies that look at how different drugs affect blood chemistry, heart function, liver function, and more.
Some of the major players in the clinical chemistry devises for laboratory animal models market are Hitachi, STARR Life Sciences, Roche, Abbott Point of Care, Diatron, Olympus, Alfa Wassermann, Beckman, Acuvet Biotech, Hitachi.
The clinical chemistry devises for laboratory animal models market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Chemistry Devises for Laboratory Animal Models Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Clinical Chemistry Devises for Laboratory Animal Models Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Clinical Chemistry Devises for Laboratory Animal Models Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Clinical Chemistry Devises for Laboratory Animal Models Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Clinical Chemistry Devises for Laboratory Animal Models Market Size & Forecast, 2018-2028 4.5.1 Clinical Chemistry Devises for Laboratory Animal Models Market Size and Y-o-Y Growth 4.5.2 Clinical Chemistry Devises for Laboratory Animal Models Market Absolute $ Opportunity
Chapter 5 Global Clinical Chemistry Devises for Laboratory Animal Models Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
5.2.1 Albumin Analyzers
5.2.2 Cardiac Marker Analyzers
5.2.3 Clinical Chemistry Analyzers
5.2.4 CO-Oximeter
5.2.5 Creatinine Analyzer
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Clinical Chemistry Devises for Laboratory Animal Models Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
6.2.1 Laboratory
6.2.2 University
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Clinical Chemistry Devises for Laboratory Animal Models Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
9.1 Introduction
9.2 North America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
9.6.1 Albumin Analyzers
9.6.2 Cardiac Marker Analyzers
9.6.3 Clinical Chemistry Analyzers
9.6.4 CO-Oximeter
9.6.5 Creatinine Analyzer
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
9.10.1 Laboratory
9.10.2 University
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
10.1 Introduction
10.2 Europe Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
10.6.1 Albumin Analyzers
10.6.2 Cardiac Marker Analyzers
10.6.3 Clinical Chemistry Analyzers
10.6.4 CO-Oximeter
10.6.5 Creatinine Analyzer
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
10.10.1 Laboratory
10.10.2 University
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
11.6.1 Albumin Analyzers
11.6.2 Cardiac Marker Analyzers
11.6.3 Clinical Chemistry Analyzers
11.6.4 CO-Oximeter
11.6.5 Creatinine Analyzer
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
11.10.1 Laboratory
11.10.2 University
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
12.1 Introduction
12.2 Latin America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
12.6.1 Albumin Analyzers
12.6.2 Cardiac Marker Analyzers
12.6.3 Clinical Chemistry Analyzers
12.6.4 CO-Oximeter
12.6.5 Creatinine Analyzer
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
12.10.1 Laboratory
12.10.2 University
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
13.6.1 Albumin Analyzers
13.6.2 Cardiac Marker Analyzers
13.6.3 Clinical Chemistry Analyzers
13.6.4 CO-Oximeter
13.6.5 Creatinine Analyzer
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
13.10.1 Laboratory
13.10.2 University
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Clinical Chemistry Devises for Laboratory Animal Models Market: Competitive Dashboard
14.2 Global Clinical Chemistry Devises for Laboratory Animal Models Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hitachi
14.3.2 STARR Life Sciences
14.3.3 Roche
14.3.4 Abbott Point of Care
14.3.5 Diatron
14.3.6 Olympus
14.3.7 Alfa Wassermann
14.3.8 Beckman
14.3.9 Acuvet Biotech
14.3.10 Hitachi